(NRC) as a Liquidity Pulse for Institutional Tactics
This article provides an AI-driven analysis of National Research Corporation (NYSE: NRC), highlighting weak near and mid-term sentiment, despite a strong long-term outlook. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including support and resistance levels. The analysis emphasizes an exceptional risk-reward setup targeting an 18.8% gain for long-term positions.
National Research: Q4 Earnings Snapshot
National Research Corp. (NRC) reported Q4 earnings of $1.8 million, or 8 cents per share, with adjusted earnings of 16 cents per share. The company's revenue for the quarter was $35.2 million. For the full year, NRC posted a profit of $11.6 million, or 50 cents per share, on revenue of $137.4 million.
How NRC Health's patient experience tech rose to #1 in 2026 KLAS
NRC Health has been awarded the 2026 Best in KLAS Award for Healthcare Experience Management for the third time in four years, recognizing its leadership in humanizing healthcare through technology and data-driven insights. The company designs solutions with partners to improve patient and employee experiences, offering a 360-degree view for informed decision-making. KLAS CEO Adam Gale emphasized that the award signifies vendor excellence in partnering with healthcare organizations to improve patient care and outcomes.
(NRC) Risk Channels and Responsive Allocation
This article provides an analysis of National Research Corporation (NYSE: NRC), highlighting weak near-term sentiment but strong long-term prospects. It outlines various AI-generated trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging, based on multi-timeframe signal analysis. The report also details current support and resistance levels and an exceptional risk-reward setup for the stock.
National Research (NRC) Margin Compression Reinforces Bearish Earnings Narratives
National Research (NRC) recently reported its Q3 FY 2025 earnings, revealing revenue of US$34.6 million and EPS of US$0.18. The company has experienced a long run of declining earnings and compressing net profit margins, now at 11.6% compared to 18.8% the previous year, reinforcing bearish narratives despite remaining profitable in Q3. Its valuation sits between industry and peer averages, with the share price currently above a DCF fair value estimate.
National Research Q4 2025 Earnings Call Transcript
National Research (NRC Health) reported Q4 2025 revenue of $35.2 million, a 5% year-over-year decrease, and full-year revenue of $137.4 million, down 4% from 2024. Despite the revenue decline, Total Recurring Contract Value (TRCV) grew 8% year-over-year to $144.1 million, marking the fifth consecutive quarter of sequential TRCV growth. The company maintained strong profitability with a full-year adjusted EBITDA of $40.2 million (29% margin) and highlighted successful go-to-market strategies, strengthened customer retention, and investments in enablement solutions and AI-powered product innovation as key growth catalysts for 2026.
NRC 2025 Earnings Report: $11.6M Annual Profit | Healthcare Advisor - News and Statistics
National Research Corp. (NRC) reported a fourth-quarter profit of $1.8 million, or 8 cents per share, with adjusted earnings of 16 cents per share. The company, an advisor to healthcare providers, posted fourth-quarter revenue of $35.2 million. For the full 2025 fiscal year, NRC achieved a profit of $11.6 million, or 50 cents per share, on annual revenue of $137.4 million.
National Research: Fourth Quarter Earnings Overview
National Research Corp. announced its financial results for the fourth quarter, reporting a net income of $1.8 million and adjusted earnings of $0.16 per share on revenues of $35.2 million. For the full fiscal year, the company achieved a profit of $11.6 million and total revenues of $137.4 million, confirming its role as a healthcare consultant.
National Research Declares Quarterly Dividend of $0.16
National Research (NRC) has declared a quarterly dividend of $0.16 per share, maintaining consistency with previous distributions and signaling confidence in its financial health. This dividend offers a forward yield of 2.92%, making it attractive to investors seeking stable returns. The payment is scheduled for April 10, with record and ex-dividend dates on March 27.
National Research: Fourth Quarter Earnings Overview
National Research Corp. has announced its financial results for the fourth quarter, reporting a net income of $1.8 million and adjusted earnings of $0.16 per share on revenue of $35.2 million. For the full fiscal year, the company posted a profit of $11.6 million and annual revenue of $137.4 million. National Research Corp. provides consulting services to healthcare organizations.
National Research: Fourth Quarter Earnings Overview
National Research Corp. announced its financial results for the fourth quarter, reporting a net income of $1.8 million and earnings of $0.08 per share, or $0.16 per share when adjusted for one-time expenses. The company's revenue for the quarter reached $35.2 million, contributing to a full fiscal year profit of $11.6 million on $137.4 million in revenue. National Research Corp. provides consulting services to healthcare organizations.
Top Research Reports for Meta, Palantir and Amphenol
This article highlights key research reports for major stocks including Meta Platforms (META), Palantir Technologies (PLTR), and Amphenol Corp. (APH), as well as National Research Corp. (NRC). It details the financial performance and analyst sentiment for each company, noting strengths like user growth for Meta and AI strategy for Palantir, alongside challenges like competition and economic uncertainty. The report also briefly covers other stocks and Zacks' "Ahead of Wall Street" daily article.
National Research Corporation (NRC): Investor Outlook on a Healthcare Data Pioneer with a Strong Return on Equity
National Research Corporation (NRC), a healthcare information services company, shows a strong return on equity (ROE) of 66.87%, despite a negative revenue growth of -3.40%. The company, valued at $456.89 million, specializes in analytics for patient and employee experiences and recently introduced an advanced AI engine, Huey AI. Trading at $19.81, NRC offers a dividend yield of 2.62% and a strong free cash flow, but lacks traditional valuation metrics and analyst coverage.
NRC: Integrating NPS and HCAHPS with timely, focused action accelerates patient experience gains
This article highlights how integrating NPS and HCAHPS data with timely feedback and demographic insights can improve patient experience and financial outcomes. The key is to focus on long-term trends, prioritize high-impact behaviors, and foster supportive leadership, as demonstrated by National Research Corporation (NRC). This approach helps accelerate gains in patient satisfaction.
National Research (NASDAQ:NRC) Stock Price Passes Above 200-Day Moving Average - Time to Sell?
National Research (NASDAQ:NRC) saw its stock price rise above its 200-day moving average to $21.07, despite trading down 4.3% on Friday morning. The company, which has a market cap of $477.5M and high leverage, recently had its rating upgraded by Weiss Ratings from "sell" to "hold." Institutional investors have been adjusting their stakes in NRC, with several increasing their holdings in recent quarters.
(NRC) Movement as an Input in Quant Signal Sets
This article from Stock Traders Daily discusses how the movement of National Research Corporation (NYSE: NRC) is used as an input in quantitative signal sets. It highlights strong sentiment across all time horizons supporting an overweight bias for NRC, even with elevated downside risk. The analysis includes AI-generated trading strategies for different risk profiles and provides specific entry zones, targets, and stop losses.
National Research Corporation (NRC) Stock Analysis: A Healthcare Sector Contender with Impressive ROE and Dividend Yield
National Research Corporation (NASDAQ: NRC) is a strong player in the healthcare sector, offering business analytics to improve patient and employee experiences. Despite a slight revenue decline, the company boasts an impressive 66.87% Return on Equity and a 2.33% dividend yield. Its innovative Huey AI platform and solid technical indicators make it an appealing option for investors looking for growth and income in the healthcare industry.
National Research's (NASDAQ:NRC) earnings trajectory could turn positive as the stock jumps 10% this past week
National Research Corporation's stock has seen a significant 78% rise in the last quarter, though its performance over the past five years has been disappointing with a 56% decline. The company's earnings per share have also dropped by 14% annually over the same period, closely tracking the share price fall, suggesting market sentiment has remained consistent. Despite the recent positive momentum and a 26% total shareholder return over the last year, the long-term underperformance warrants caution.
National Research Corporation's (NASDAQ:NRC) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 13% Over the Past Week
National Research Corporation's stock has performed well, rising 13% in the past week and 32% over the year, which benefits its large institutional owners who hold 51% of the company. The top 10 shareholders collectively own 51% of the company, with insiders holding 22% of shares, and the CEO holding 2.2%. The article notes that while significant institutional ownership can indicate credibility, investors should also consider other factors and warnings signs.
National Research's (NASDAQ:NRC) earnings trajectory could turn positive as the stock jumps 10% this past week
National Research Corporation (NASDAQ:NRC) has seen its stock jump 78% in the last quarter, though it still lags significantly over the past five years with a 56% decline. The company's earnings per share (EPS) have also declined by 14% annually over the last five years, closely mirroring the share price drop. Despite the long-term underperformance, recent positive momentum and a 26% total shareholder return over the last 12 months (including dividends) suggest a potential turnaround.
National Research's (NASDAQ:NRC) earnings trajectory could turn positive as the stock jumps 10% this past week
National Research Corporation (NASDAQ:NRC) has seen a 10% stock jump in the past week and a 78% increase in the last quarter, signaling a potential positive shift. However, the company's performance over the last five years has been disappointing, with a 56% share price decline and a 14% annual EPS drop. Investors should exercise caution despite the recent gains, as long-term fundamentals still reflect underperformance.
National Research Stock: The Turnaround Is Invisible Until It Isn't (NASDAQ:NRC)
National Research Corp. (NRC) is currently undervalued, trading at a modest multiple despite clear indicators of a shift from contraction to growth. Key metrics like TRCV show a strong year-over-year increase, signaling upcoming revenue acceleration and a positive outlook for 2026. With expanding margins, potential normalized free cash flow approaching $38M, and a revitalized sales force, NRC is positioned for significant upside, potentially reaching $30+ per share.
National Research (NASDAQ:NRC) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell?
National Research (NASDAQ:NRC) stock recently broke above its 200-day moving average, reaching $18.80, yet analysts maintain a "Sell" consensus rating. The company increased its quarterly dividend to $0.16, but its high dividend payout ratio of 91.43% and debt-to-equity ratio of 5.31 raise concerns about sustainability and financial health. Institutional investors have seen some activity, with several hedge funds adjusting their stakes in NRC.
National Research Corp (NASDAQ:NRC) Nasdaq 100 Index Health Metrics
This article focuses on National Research Corp (NASDAQ:NRC) and its relevance to the Nasdaq 100 Index, emphasizing its data-driven tools that assist healthcare organizations in understanding patient and employee experiences. NRC helps identify experience gaps, improve patient engagement, and supports quality initiatives by aligning experience metrics with outcomes. The complete article content requires a login or new account creation.
National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened
National Research Corporation (NASDAQ:NRC) saw its stock price rise above its two hundred day moving average, reaching $18.01 before settling at $18.00. This technical breakout occurred despite negative analyst sentiment, with Weiss Ratings reiterating a "sell" rating. The company also announced an increase in its quarterly dividend to $0.16 per share, offering a 3.6% yield.
Precision Trading with National Research Corporation (NRC) Risk Zones
This article provides a detailed analysis of National Research Corporation (NRC) stock, highlighting a neutral sentiment across all time horizons indicating sideways action. It outlines AI-generated trading strategies including Position, Momentum Breakout, and Risk Hedging strategies, along with key support and resistance levels. The analysis emphasizes elevated downside risk due to a lack of additional long-term support signals despite an ongoing breakout.
NRC Health (NRC) teams with Mosaic Life Care to enhance patient and caregiver experience
NRC Health and Mosaic Life Care have announced a new partnership aimed at elevating the patient and employee experience. Mosaic Life Care, a physician-led health system in northwest Missouri, selected NRC Health for its advanced technology and human-centered approach to experience management. This collaboration will provide Mosaic with real-time feedback and actionable data to enhance care and reinforce its commitment to human-centered healthcare.
Projects funded by the Arctic and Northern Challenge program
The Arctic and Northern Challenge program funds collaborative research projects focused on using technology and innovation to address critical issues in the North and Arctic regions, guided by Northern communities. These projects, ranging from enhancing mental health through virtual reality to improving search and rescue operations, aim to solve pressing problems identified by those living there. The initiatives cover diverse areas including environmental monitoring, energy efficiency, and health care, all benefiting from grants and contributions from the NRC's Collaborative Science, Technology and Innovation Program.
National Research Corporation's (NASDAQ:NRC) Shares Climb 51% But Its Business Is Yet to Catch Up
National Research Corporation's share price saw a 51% gain recently, recovering from previous weakness, but still showing a 10% decline over the last year. Despite the rally, its P/E ratio of 24.7x is high compared to the market, and the company's earnings have fallen significantly over the past year and three years. This disparity between share price performance and declining earnings suggests potential overvaluation, raising concerns for current and prospective shareholders.
NRC Health (NASDAQ: NRC) reports $13.8M operating cash flow, up 46% YoY on retention gains
NRC Health (NASDAQ: NRC) announced its third-quarter 2025 results, featuring an 8% year-over-year increase in Total Recurring Contract Value (TRCV) to $141.7 million, alongside a 46% rise in cash flow from operations to $13.8 million. The company attributes this growth to strong sales and improved customer retention, reflecting the effectiveness of its healthcare experience improvement solutions. NRC Health also increased its quarterly cash dividend by 33% to $0.16 per share.
NRC Health (NRC) and BJC HealthCare unite on data-driven patient, employee experience
NRC Health has announced a new partnership with BJC Health System to enhance patient and employee experiences across BJC's network. Through this collaboration, NRC Health will provide its Patient Experience, Leader, and Employee Rounding solutions to unify feedback and drive measurable outcomes. This partnership aims to strengthen human connections in healthcare and advance experience excellence.
NATIONAL RESEARCH CORP SEC 10-Q Report
National Research Corp (NRC) has released its Q3 2025 Form 10-Q report, detailing a 3% decrease in revenue to $34.6 million and a net income of $4.1 million, down from $5.7 million in the prior year. The company attributes revenue decline to decreased recurring revenue from existing clients and notes impacts on net income from higher interest expenses and taxes. Despite financial decreases, NRC plans continued investment in innovation and anticipates future revenue growth from sustaining Total Recurring Contract Value.
Will National Research Corporation continue its uptrend - 2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
The requested page on Newser.com could not be found. The article titled "Will National Research Corporation continue its uptrend" appears to be unavailable, and the website suggests navigating to its homepage or other sections for news.
Mercy Earns NRC Health Excellence Award as Top Large System (4th Year) | NRC Stock News - Stock Titan
Mercy has been honored by NRC Health for the fourth consecutive year with the Excellence in Patient Experience Award, recognizing it as the top large health system in the country. This distinction is based on patient recommendation ratings collected from April 1, 2024, through March 31, 2025, with Mercy being one of only three U.S. health systems to receive the award in 2025. The healthcare provider annually collects feedback from over 1.25 million patients and provides extensive free care and community benefits.
Mercy Earns National Honor for Excellence in Patient Experience – Company Announcement - Financial Times
For the fourth consecutive year, Mercy has been awarded the Excellence in Patient Experience Award by NRC Health, recognizing it as the top large health system in the U.S. for patient experience. The award is based on feedback from over 1.25 million Mercy patients annually and highlights the dedication of their entire team, from clinical staff to support services and volunteers. This distinction underscores Mercy's commitment to improving patient care and its collaboration with NRC Health to capture and respond to patient feedback.
NRC Health Honors 2025 Leaders in Patient Experience and Loyalty – Company Announcement - Financial Times
NRC Health announced the recipients of its 2025 Consumer Loyalty Awards, Excellence in Patient Experience Awards, and Excellence in Experience Management Award, recognizing top healthcare organizations for their commitment to human-centered care and patient satisfaction. The awards highlight organizations that excel in consumer loyalty, patient experience, and integrating patient feedback into their operations, with Parkview Health receiving the Excellence in Experience Management Award. The selections are based on comprehensive surveys and real-time patient feedback data.
NRC Health Honors 2025 Leaders in Patient Experience and Loyalty (2025-10-15) - Seeking Alpha
NRC Health announced the recipients of its 2025 Consumer Loyalty Awards, Excellence in Patient Experience Awards, and Excellence in Experience Management Award, recognizing top healthcare organizations for their commitment to patient-centered care and loyalty. The awards highlight organizations that excel in brand reputation, consumer trust, patient experience, and integrate patient feedback into their decision-making. Parkview Health received the Excellence in Experience Management Award for its culture-wide dedication to embedding patient and consumer feedback.
National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
National Research Corporation (NASDAQ:NRC) has announced a dividend of $0.12 per share payable on October 10th. While the yield is attractive at 3.1%, the dividend's sustainability is questionable due to a high cash payout ratio (119%) and a declining earnings per share trend over the past five years. Investors are advised to be cautious, as the company's dividend does not appear sustainable given these factors.
Canada's vinyl and fenestration industry groups announce pilot to recycle vinyl windows
The Vinyl Institute of Canada (VIC) has launched Project Win-Finity, a national pilot program aimed at recycling post-consumer polyvinyl chloride (PVC) windows. This initiative, supported by several partners including Formosa Plastics Corp. and the National Research Council of Canada, seeks to establish a circular recycling system for vinyl windows across Canada. The project aims to divert vinyl and glass from landfills, reduce CO2 emissions, conserve raw materials, and contribute to minimizing plastic waste in the construction sector.
National research corp investor Patrick Beans buys $33,973 in stock By Investing.com
Patrick E. Beans, a significant shareholder and ten percent owner of National Research Corp (NASDAQ: NRC), has purchased an additional 2,500 shares of the company's common stock for $33,973. This transaction, occurring on May 12, 2025, aligns with the company's active share buyback program and precedes several executive changes and a declared cash dividend.
Community Business Briefs
This article provides several community business briefs for Zanesville, Ohio. Key announcements include Genesis HealthCare System no longer accepting MediGold Medicare Advantage insurance from January 1, Jason Newton's promotion at Century National Bank, Interim HealthCare being named a Top Agency for the eighth consecutive year, Dr. Razvi Razack joining Genesis Digestive Disease Specialists, John Coler of Shriver’s Corp. lobbying in Washington D.C. on behalf of community pharmacies, Mohamed Tegany appointed as a lecturer at Ohio University Zanesville, and Genesis Hospice Care quality data now available online.
Lake Crossing earns national award
Lake Crossing Health Center in Appling received the Excellence in Action award from My InnerView by National Research Corp. This national honor recognizes post-acute care facilities that achieve top 10 percent resident or employee satisfaction scores in My InnerView's database. This marks the fourth consecutive year Lake Crossing has earned this prestigious award for its customer and workforce satisfaction.
